Short answer · Medically reviewed summary · Last updated: 2026-04-07
Apert Syndrome is officially recognized in medical literature as acrocephalosyndactyly type I, a term that describes the characteristic skull shape and finger webbing associated with the condition. Historical and Alternative Names Because Apert Syndrome was first described by French pediatrician Eugène Apert in 1906, it is sometimes referred to as Apert’s syndrome or the Apert-Crouzon disease complex in older texts. In clinical records, you may also encounter the abbreviation AS or the descriptive label acrocephalosyndactyly type I (ACS I).
Apert Syndrome is officially recognized in medical literature as acrocephalosyndactyly type I, a term that describes the characteristic skull shape and finger webbing associated with the condition.
Because Apert Syndrome was first described by French pediatrician Eugène Apert in 1906, it is sometimes referred to as Apert’s syndrome or the Apert-Crouzon disease complex in older texts. In clinical records, you may also encounter the abbreviation AS or the descriptive label acrocephalosyndactyly type I (ACS I). Historically, the term "acrocephalosyndactyly" was used as an umbrella classification for various craniosynostosis disorders; however, Apert Syndrome is now clearly distinguished from other types (such as Pfeiffer or Carpenter syndromes) due to its specific genetic cause, typically a mutation in the FGFR2 gene.
In modern medical classification systems, the condition is consistently indexed as follows:
Medical professionals currently prefer the term Apert Syndrome. The shift away from purely descriptive, Latinized names toward the eponym reflects the need for precise diagnostic criteria. While older medical records might use "acrocephalosyndactyly," the use of the eponym Apert Syndrome is now the international standard to ensure clarity in multidisciplinary care, which often involves neurosurgery, plastic surgery, and genetics.
The existence of multiple names is largely a product of medical history. Before the advent of molecular genetics, clinicians classified rare diseases based solely on physical observations (phenotypes). As our understanding of the specific genetic pathways involved in Apert Syndrome has evolved, the medical community has moved to consolidate nomenclature to prevent confusion with other forms of syndromic craniosynostosis. Using the standardized name helps families navigate global research databases and ensures that clinical information remains consistent across international borders.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.